Influence of Hypoglycemic Combined with Lipid-lowering Statin Therapy on Lipid Profile of Mixed Dyslipid-emia Patients with T2DM
10.6039/j.issn.1001-0408.2015.32.33
- VernacularTitle:降糖联合他汀降脂疗法对混合型血脂异常的2型糖尿病患者血脂的影响
- Author:
Wenjie PAN
;
Liangmiao CHEN
;
Weiwen SUN
;
Peng HUANG
- Publication Type:Journal Article
- Keywords:
Hypoglycemic;
Statins;
Mixed dyslipidemia;
Type 2 diabetes mellitus
- From:
China Pharmacy
2015;(32):4557-4559
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the influence of hypoglycemic combined with lipid-lowering statin therapy on lipid profile of mixed dyslipidemia patients with T2DM and TG in 2.3-4.5 mmol/L. METHODS:In total of 80 patients with T2DM and mixed dyslip-idemia of TG in 2.3-4.5 mmol/L in our hospital was determined according to the patient’s age,chronic complications of diabetes and life expectancy. Hypoglycemic(insulin joint oral hypoglycemic drugs,or oral antidiabetic drug alone)treatment was given according to corresponding target,meanwhile statin lipid-lowering therapy was also given. HbA1c,TG,TC,HDL-C and LDL-C were determined and BMI was calculated before treatment. Alipid was reviewed after two weeks,then the difference was compared. RESULTS:Com-pared with before treatment,TG,TC and LDL-C were decreased by 50.28%,42.91% and 44.37% after hypoglycemic combined with lipid-lowering statin therapy,with significant difference(P<0.01). Insulin was the better choice to reduce the level of TG,there was significant difference between insulin treatment and oral hypoglycemic drugs alone (P<0.05). CONCLUSIONS:For T2DM patients with mixed dyslipidemia of TG between 2.3-4.5 mmol/L,hypoglycemic combined with lipid-lowering statin therapy can not only signifi-cantly reduce the levels of TG,TC,LDL-C and TG to 2.3 mmol/L or less,and even normal. Compared with oral hypoglycemic drugs alone,the compliance rate of TG was higher in the combination of insulin and oral hypoglycemic drugs.
